Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
PhoreMost’s £33m investment success for disease targets
25 March 2021
Cambridge Angels
PhoreMost’s £33m investment success for disease targets
Cambridge Angels
25 March 2021

PhoreMost’s £33m investment success for disease targets

Cambridge Angels
25 March 2021

Source:https://www.cambridgeindependent.co.uk/business/phoremost-s-33m-investment-success-for-disease-targets-9192413/

Newer PostPsyomics pilots digital mental health assessment Censeo
Older PostFeaturespace founder talks the future of financial crime & deep learning
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net